Differential effects of clorgyline on sensitization to quinpirole in rats tested in small and large environments

Psychopharmacology

Volumn 186, Issue 4, 2006, Pages 534-543

  Dvorkin, Anna ^a   Culver, Kirsten E ^b   Szechtman, Henry ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Clorgyline; D2 D3 receptor agonist; Locomotor activity; MAOI; Open field; Quinpirole; Sensitization; Standard deviational ellipse

Indexed keywords

CLORGYLINE; DOPAMINE RECEPTOR STIMULATING AGENT; QUINPIROLE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SENSITIZATION; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; RAT STRAIN; STEREOTYPY;

ANIMALS; BEHAVIOR, ANIMAL; CLORGYLINE; DOPAMINE AGONISTS; DRUG INTERACTIONS; ENVIRONMENT, CONTROLLED; MALE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; QUINPIROLE; RATS; RATS, LONG-EVANS; STEREOTYPED BEHAVIOR;

EID: 33744954753     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0377-4     Document Type: Article

References (57)

1. Arnt J, Hyttel J, Perregaard J (1987) Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Eur J Pharmacol 133:137-145
2. Aulakh CS, Hill JL, Murphy DL (1993) Attenuation of hypercortisolemia in fawn-hooded rats by antidepressant drugs. Eur J Pharmacol 240:85-88
3. Badiani A, Robinson TE (2004) Drug-induced neurobehavioral plasticity: the role of environmental context. Behav Pharmacol 15:327-339
4. Campbell IC, Robinson DS, Lovenberg W, Murphy DL (1979) The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain. J Neurochem 32:49-55
5. Campbell IC, Durcan MJ, Cohen RM, Pickar D, Chugani D, Murphy DL (1985) Chronic clorgyline and pargyline increase apomorphine-induced stereotypy in the rat. Pharmacol Biochem Behav 23:921-925
6. Canadian Council on Animal Care (1993) Guide to the care and use of experimental animals, vol 1, 2nd edn. CCAC, Ottawa, Ontario, Canada
7. Cleveland WS (1979) Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74:829-836
8. Culver KE, Szechtman H (1997) Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole. Eur J Pharmacol 339:109-111
9. Culver KE, Szechtman H (2003) Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline 12 receptors. Psychopharmacology (Berl) 167:211-218
10. Culver KE, Szechtman H (2004) Hypophysectomy does not block sensitization to the dopamine agonist quinpirole or its modulation by the MAOI clorgyline. Horm Behav 45:23-30
11. Culver KE, Rosenfeld JM, Szechtman H (2000) A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats. Psychopharmacology (Berl) 151:202-210
12. Culver KE, Rosenfeld JM, Szechtman H (2002) Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition. Neuropharmacology 43:385-393
13. Drai D, Golani I (2001) SEE: a tool for the visualization and analysis of rodent exploratory behavior. Neurosci Biobehav Rev 25:409-426
14. Drai D, Benjamini Y, Golani I (2000) Statistical discrimination of natural modes of motion in rat exploratory behavior. J Neurosci Methods 96:119-131
15. Drai D, Kafkafi N, Benjamini Y, Elmer G, Golani I (2001) Rats and mice share common ethologically relevant parameters of exploratory behavior. Behav Brain Res 125:133-140
16. Eilam D, Szechtman H (1989) Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur J Pharmacol 161:151-157
17. Eilam D, Szechtman H (2005) Psychostimulant-induced behavior as an animal model of obsessive-compulsive disorder: an ethological approach to the form of compulsive rituals. CNS Spectr 10:191-202
18. Eilam D, Clements KV, Szechtman H (1991) Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats. Behav Brain Res 45:117-124
19. Eilam D, Talangbayan H, Canaran G, Szechtman H (1992) Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors. Psychopharmacology (Berl) 106:447-454
20. Fang J, Yu PH (1994) Effect of L-deprenyl, its structural analogues and some monoamine oxidase inhibitors on dopamine uptake. Neuropharmacology 33:763-768
21. Golani I, Benjamini Y, Eilam D (1993) Stopping behavior: constraints on exploration in rats (Rattus norvegicus). Behav Brain Res 53:21-33
22. Greenshaw AJ (1986) Osmotic mini-pumps: a convenient program for weight-adjusted filling concentrations. Brain Res Bull 16:759-761
23. Haefely W, Burkard WP, Cesura AM, Kettler R, Lorez HP, Martin JR, Richards JG, Scherschlicht R, Da Prada M (1992) Biochemistry and pharmacology of moclobemide, a prototype RIMA. Psychopharmacology (Berl) 106:S6-S14
24. Imperato A, Tanda G, Frau R, Di Chiara G (1988) Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. J Pharmacol Exp Ther 245:257-264
25. Itzhak Y, Mash D, Zhang SH, Stein I (1991a) Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites. Mol Pharmacol 39:385-393
26. Itzhak Y, Stein I, Zhang SH, Kassim CO, Cristante D (1991b) Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes. J Pharmacol Exp Ther 257:141-148
27. Kettler R, Da Prada M, Burkard WP (1990) Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in rats. Acta Psychiatr Scand Suppl 360:101-102
28. Koeltzow TE, Austin JD, Vezina P (2003) Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow. Neuropharmacology 44:102-110
29. Lai JC, Leung TK, Guest JF, Lim L, Davison AN (1980) The monoamine oxidase inhibitors clorgyline and L-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations. Biochem Pharmacol 29:2763-2767
30. Lee SP, So CH, Rashid AJ, Varghese G, Cheng R, Lanca AJ, O'Dowd BF, George SR (2004) Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 279:35671-35678
31. Lefever DW (1926) Measuring geographic concentration by means of the standard deviation ellipse. AJS 32:88-94
32. Levant B (2002) Novel drug interactions at D2 dopamine receptors: modulation of [3H]quinpirole binding by monoamine oxidase inhibitors. Life Sci 71:2691-2700
33. Levant B, Grigoriadis DE, DeSouza EB (1993) Monoamine oxidase inhibitors inhibit [3H]quinpirole binding in rat striatal membranes. Eur J Pharmacol 246:171-178
34. Levant B, Moehlenkamp JD, Morgan KA, Leonard NL, Cheng CC (1996) Modulation of [H-3]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site. J Pharmacol Exp Ther 278:145-153
35. Levant B, Gilliland SL, Culver KE, Szechtman H (2000) Novel drug interactions at CNS dopamine receptors: potential role in psychopathology and toxicity. In: Williams GM, Aruoma OI (eds) Molecular drug metabolism and toxicity. OICA, St. Lucia, pp 201-216
36. Levant B, Morgan KA, Ahlgren-Beckendorf JA, Grandy DK, Chen K, Shih JC, Seif I (2001) Modulation of [3H]quinpirole binding at striatal D2 dopamine receptors by a monoamine oxidase A-like site: evidence from radioligand binding studies and D2 receptor- and MAO(A)-deficient mice. Life Sci 70:229-241
37. Levine N (2004) CrimeStat III: a spatial statistics program for the analysis of crime incident locations (version 3.0). Ned Levine & Associates, Houston, TX/National Institute of Justice, Washington, DC. Available at http://www.nedlevine.com/nedlevine17.htm
38. Lione LA, Nutt DJ, Hudson AL (1998) Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline 12 receptors. Eur J Pharmacol 353:123-135
39. Noldus LP, Trienes RJ, Hendriksen AH, Jansen H, Jansen RG (2000) The Observer Video-Pro: new software for the collection, management, and presentation of time-structured data from videotapes and digital media files. Behav Res Methods Instrum Comput 32:197-206
40. Noldus LP, Spink AJ, Tegelenbosch RA (2001) EthoVision: a versatile video tracking system for automation of behavioral experiments. Behav Res Methods Instrum Comput 33:398-414
41. Olmos G, Gabilondo AM, Miralles A, Escriba PV, Garcia-Sevilla JA (1993) Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain. Br J Pharmacol 108:597-603
42. Piazza PV, Deminiere JM, Le Moal M, Simon H (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245:1511-1513
43. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157-198
44. Segal DS, Schuckit MA (1983) Animal models of stimulant-induced psychosis. In: Creese I (ed) Stimulants: neurochemical, behavioral and clinical perspectives. Raven, NY, pp 131-167
45. Segal DS, Kuczenski R, Okuda C (1992) Clorgyline-induced increases in presynaptic DA: changes in the behavioral and neurochemical effects of amphetamine using in vivo microdialysis. Pharmacol Biochem Behav 42:421-429
46. So CH, Varghese G, Curley KJ, Kong MM, Alijaniaram M, Ji X, Nguyen T, O'Dowd BF, George SR (2005) D1 and d2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor. Mol Pharmacol 68:568-578
47. Spink AJ, Tegelenbosch RA, Buma MO, Noldus LP (2001) The EthoVision video tracking system - a tool for behavioral phenotyping of transgenic mice. Physiol Behav 73:731-744
48. Sullivan R, Dogaru C, Szechtman H (1992) Constriction of environmental space and the behavioral response to the dopamine agonist quinpirole. Pharmacol Biochem Behav 43:1217-1219
49. Szechtman H (2004) Context gives meaning. Commentary on Badiani and Robinson drug-induced neurobehavioral plasticity: the role of environmental context. Behav Pharmacol 15:381-385
50. Szechtman H, Talangbayan H, Eilam D (1993) Environmental and behavioral components of sensitization induced by the dopamine agonist quinpirole. Behav Pharmacol 4:405-410
51. Szechtman H, Dai H, Mustafa S, Einat H, Sullivan RM (1994a) Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole. Pharmacol Biochem Behav 48:921-928
52. Szechtman H, Talangbayan H, Canaran G, Dai H, Eilam D (1994b) Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism [published erratum appears in Psychopharmacology (Berl) 116(1):124, 1994 (Sep)]. Psychopharmacology (Berl) 115:95-104
53. Szechtman H, Sulis W, Eilam D (1998) Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). Behav Neurosci 112:1475-1485
54. Szechtman H, Culver K, Eilam D (1999) Role of dopamine systems in obsessive-compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model. Pol J Pharmacol 51:55-61
55. Szumlinski KK, Allan M, Talangbayan H, Tracey A, Szechtman H (1997) Locomotor sensitization to quinpirole: environment-modulated increase in efficacy and context-dependent increase in potency. Psychopharmacology (Berl) 134:193-200
56. Tukey JW (1977) Exploratory data analysis. Addison-Wesley, Reading, MA
57. Ventura MA (1982) Effects of clorgyline and deprenil on corticosterone levels in rats. Eur J Pharmacol 81:349-355